-
Lenalidomide boosts CD1d-Vδ2 bispecific antibody-engaged Vγ9Vδ2-T cell effector functions via CD28, Notch signaling and IL-2 release
de Jong, M., Veth, M., Brachtlová, T., King, L. A., Saura-Esteller, J., Bechler, T. M., van Helden, P. M., Alhan, C., Lameris, R., de Gruijl, T. D. & van der Vliet, J. J., 28 Jun 2026, In: Journal for Immunotherapy of Cancer. 14, 6Research output: Contribution to Journal › Article › Academic › peer-review
-
Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future
Saura-Esteller, J., de Jong, M., King, L. A., Ensing, E., Winograd, B., de Gruijl, T. D., Parren, P. W. H. I. & van der Vliet, H. J., 16 Jun 2022, In: Frontiers in immunology. 13, 915837.Research output: Contribution to Journal › Review article › Academic › peer-review
- All publications
